Tom Arnhart

Tom Arnhart is an accomplished professional with extensive experience in the pharmaceutical and healthcare industries, currently serving as Account Director for Value & Access Strategy at Xcenda since October 2023. Previous roles include Director of Field HEOR at Ultragenyx Pharmaceutical Inc., and Director of Field HEOR Liaison at Sage Therapeutics, Inc. Tom has held positions such as Clinical Value & Outcomes Liaison at Alexion Pharmaceuticals and Regional Account Scientific Director at Novartis Oncology. A solid foundation in managed markets was built during tenure as Director of Medical Sciences at MedImmune and as National Account Manager at Cephalon, Inc. Educational credentials include a Pharm.D. from The University of Tennessee Health Science Center, a Master of Science in Pharmaceutical Outcomes & Policy from the University of Florida, and a Bachelor of Science in Biology from Tennessee Technological University.